title: Expression patterns of AMOG in developing human cortex and malformations of cortical development.
abstract: Adhesion molecule on glia (AMOG) mediates neuronal migration during development and ion homeostasis. Recently, AMOG has been identified as a regulator of the Pi3K-mTOR signaling pathway. In the present study, we investigated the expression pattern of AMOG in human cortex during development and in focal malformations of cortical development. In the developing human cortex, AMOG expression was detected in the cortical plate at 13 gestational weeks and increased in later gestational ages. In adult human control cortex, a diffuse immunoreactivity pattern was observed for AMOG in the grey matter. In the white matter, AMOG was expressed in perivascular astrocytes. In focal cortical dysplasia (n=6) and cortical tubers (n=6), the diffuse AMOG expression pattern was reduced in the grey matter. However, AMOG immunoreactivity was observed in reactive astrocytes and strong perisomatic staining was detected in balloon and giant cells. Double-labeling showed co-localization of AMOG with the precursor cell marker CD34 and phosphorylated S6, used as a marker of mTOR activation. The AMOG expression pattern, with altered cellular distribution, observed in malformations of cortical development suggests that AMOG might contribute to the abnormal cortical development via mTOR activation. Whether dysfunction of AMOG might influence the ionic and osmotic regulation, contributing to neuronal hyperexcitability, deserves further investigation.
authors.affiliation: Department of (Neuro)Pathology, Academic Medical Center, University of Amsterdam, The Netherlands.
authors.forename: K
authors.initials: K
authors.lastname: Boer
authors.forename: W G M
authors.initials: WG
authors.lastname: Spliet
authors.forename: P C
authors.initials: PC
authors.lastname: van Rijen
authors.forename: F E
authors.initials: FE
authors.lastname: Jansen
authors.forename: E
authors.initials: E
authors.lastname: Aronica
mesh_terms: D000251:Adenosine Triphosphatases / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism; D000293:Adolescent; D000328:Adult; D018952:Antigens, CD34 / Q000235:genetics / Q000378:metabolism; D027682:Cation Transport Proteins / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism; D015816:Cell Adhesion Molecules, Neuronal / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism; D002540:Cerebral Cortex / Q000002:abnormalities / Q000196:embryology* / Q000378:metabolism*; D002648:Child; D002675:Child, Preschool; D004789:Enzyme Activation / Q000235:genetics; D005260:Female; D005333:Fetus / Q000201:enzymology / Q000378:metabolism / Q000473:pathology; D018507:Gene Expression Regulation, Developmental; D006801:Humans; D007223:Infant; D008297:Male; D054220:Malformations of Cortical Development / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D019893:Ribosomal Protein S6 Kinases / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000235:genetics; D058570:TOR Serine-Threonine Kinases / Q000378:metabolism / Q000502:physiology; D055815:Young Adult
chemical_list: C504190:ATP1B2 protein, human; D018952:Antigens, CD34; D027682:Cation Transport Proteins; D015816:Cell Adhesion Molecules, Neuronal; C546842:MTOR protein, human; D019893:Ribosomal Protein S6 Kinases; D058570:TOR Serine-Threonine Kinases; D000251:Adenosine Triphosphatases